Sort
46,585 grants matching “heart failure”
Novel Role of Interleukin-17 in Sympathetic Activation in Heart Failure
$577,770Shunguang Wei · University Of Iowa · R01 · FY2024 · HL
Dose-distribution radiomics to predict morbidity risk in radiotherapy
$577,764Joseph O Deasy · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA
Combined Illness Management and Psychotherapy in Treating Depressed Elders
$577,741Carolyn L Turvey · University Of Iowa · R01 · FY2014 · MH
ACHIEVE P1 - HTN
$577,737Robert D Brook · Wayne State University · P50 · FY2023 · MD
Epigenetic mechanisms of inflammatory memory propagation in human airway epithelia
$577,695Alejandro Antonio Pezzulo · University Of Iowa · R01 · FY2022 · HL
Role of mRNA-binding protein tristetraprolin in cardiac mRNA regulation and the development of heart failure
$577,630Hossein Ardehali · Northwestern University At Chicago · R01 · FY2023 · HL
Dairy Foods and Blood Pressure in Multi-Ethnic Children
$577,503Debra K Sullivan · University Of Kansas Medical Center · R01 · FY2008 · HL
Ferroptosis in the Heart: Iron Calcium Crosstalk and Compartmentalization
$577,493Lai-Hua Xie · Rutgers Biomedical And Health Sciences · R01 · FY2024 · HL
Evaluation of the effectiveness of Ajjmuurur Baamḷe DSMES in the RMI
$577,482Sheldon Riklon · Univ Of Arkansas For Med Scis · R01 · FY2025 · DK
Radiomics approach to engineering an artificial intelligence based echocardiography platform to predict cardiovascular surgery and heart failure outcomes.
$577,287William Hiesinger · Stanford University · R01 · FY2024 · HL
Determining the Role of Junctophilin-2 in Cardiac Disease
$577,274Xander H.t. Wehrens · Baylor College Of Medicine · R01 · FY2016 · HL
Trial of Pirfenidone to Prevent Progression of Chronic Kidney Disease (TOP-CKD)
$577,221Joachim H Ix · Veterans Medical Research Fdn/San Diego · U01 · FY2022 · DK
Sustaining quality of life of the aged: Heart transplant or mechanical support?
$577,106Kathleen L Grady · Northwestern University At Chicago · R01 · FY2017 · AG
Development and validation of cardiovascular MRI techniques on a low-field, ultra-wide bore system to assess patients with severe obesity
$577,077Orlando Paul Simonetti · Ohio State University · R01 · FY2023 · HL
Mechanobiological mechanisms of pulmonary hypertension secondary to left heart failure
$576,890Naomi C Chesler · University Of California-Irvine · R01 · FY2022 · HL
Oxidative Response Networks in Chagasic Cardiomyopathy
$576,843Nisha Jain Garg · University Of Texas Med Br Galveston · R01 · FY2025 · AI
Toxicology in the 21st Century Program (Tox21) - Genomic Toxicology
$576,820David Gerhold · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Protein Translation for Oxidative Stress Response in Heart Failure
$576,786Qin M Chen · University Of Arizona · R01 · FY2025 · HL
Obesity, salt-sensitivity, and the natriuretic peptides
$576,739Thomas J Wang · Vanderbilt University · R01 · FY2014 · HL
MAE-WEST SCORE Project 3 Animal
$576,738John Y-J Shyy · Cedars-Sinai Medical Center · U54 · FY2023 · AG
Phase II Trial of Metformin for Pulmonary Hypertension in Heart Failure with Preserved Ejection Fraction
$576,734Marc A Simon · University Of California, San Francisco · R01 · FY2022 · AG
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$576,722Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2021 · CA
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$576,722Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Antigenic basis of immune responses after immune modulatory therapies post-HCT
$576,722Catherine Ju-Ying Wu · Dana-Farber Cancer Inst · P01 · FY2020 · CA
Targeting FAK-NEDD9 protein-protein interaction to prevent focal adhesion assembly and vascular proliferation in pulmonary arterial hypertension
$576,691Bradley Maron · University Of Maryland Baltimore · R01 · FY2025 · HL